Years of testing ineffective neuroprotective agents to cure chronic neurodegenerative disease, it is time to test NNI's non-invasive neuroregenerative agent.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free